Skip to Content
Merck
  • Congenital glaucoma with acquired peripheral circumferential iris degeneration.

Congenital glaucoma with acquired peripheral circumferential iris degeneration.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus (2013-02-01)
Arif O Khan, Mohammed A Aldahmesh, Jawahir Y Mohamed, Fowzan S Alkuraya
ABSTRACT

Iris anomalies associated with congenital or early-childhood glaucoma include stable primary developmental abnormalities such as those associated with the Axenfeld-Rieger spectrum and aniridia. Secondary generalized iris atrophy from uncontrolled intraocular pressure is another potential iris finding in pediatric glaucoma. We document an unusual pattern of acquired peripheral circumferential iris degeneration in 2 unrelated children with otherwise-controlled congenital glaucoma. Genetic testing revealed a common homozygous CYP1B1 mutation in one (p.Gly61Glu) and a novel heterozygous FOXC1 deletion in the other (p.Tyr81_Pro95del).

MATERIALS
Product Number
Brand
Product Description

Dorzolamide hydrochloride, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Timolol maleate salt, ≥98% (TLC), powder
Dorzolamide for system suitability, European Pharmacopoeia (EP) Reference Standard